Year | Detail |
1982 |
Esaote was established as a subsidiary of IRI Finmeccanica Group, a state-owned company in Italy. |
1983 - 1988 |
Ansaldo internal division becomes part of EsaControl. This new company grew rapidly by merging with the Florence company OTE Biomedica. |
1992 |
The company has acquired its first U.S. company called Biosound by this it has started its Internationalisation of its products. |
1994 |
Esaote became a private company through an innovative management buy-out. |
2006 |
Companies second Management by objectives has launched with leading Financials groups a new company created by financial investors – Intesa Sanpaolo SpA, IMI Investimenti SpA, Tower 7 sarl, MPS Venture SGR SpA – and the managers of the Esaote Group launched another management buyout. |
2009 |
Esaote's third Management by objectives launched again with new investors Ares Life Sciences – a private equity fund specializing in investments in the biomedical and healthcare sectors, which acquired 40% of Esaote's share capital. The remaining 60% is still held by the same shareholders and by Esaote management. |
2018 |
Change of Esaote's ownership, the company was acquired by a Consortium of leading Chinese investors. The Consortium is composed of major companies in the medical and healthcare technology sectors as well as investment funds with significant experience in this field. |
2019 - 2022 |
To cope with the new scenarios dictated by the pandemic, the e-shop, Esaote's new e-commerce, the Academy, and various digital initiatives dedicated to new talents and healthcare professionals are born. |
2021 - 2022 |
Esaote joined the UN Global Compact and reinforced its actions in the field of sustainability. |
2023 |
Esaote S.p.A. and Ebit s.r.l. have obtained the Gender Equality Certification in Italy. This confirms its commitment to the well-being of individuals and the creation of a serene and respectful work environment. |